although the fda recommends imipramine hydrochloride ( imi ) only for temporary relief of symptoms of enuresis nocturna ( en ) , the drug has been applied to a number of other pediatric situations , including the hyperkinetic syndrome ( hs ) , childhood depression , somnambulism and pavor nocturnus , school phobia , petit mal epilepsy , allergies , autism , encorpresis and head-banging .
C0589978
imipramine hydrochloride
C0014394
enuresis